| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 浙江迦南科技股份有限公司成立于2000年，总部坐落于温州市永嘉工业园区，是中国制药装备行业知名的上市企业。现有成员包括南京迦南比逊科技有限公司、北京迦南莱米特科技有限公司、浙江迦南凯鑫隆科技有限公司、浙江迦南小蒋科技有限公司、上海凯贤流体科技有限公司、南京比逊弥特智能科技有限公司、云南迦南飞奇科技有限公司。迦南科技定位为产品领先型的客户专家，是国内少数能提供三种完整制粒工艺解决方案（湿法制粒、干法制粒、沸腾制粒）的制药装备企业。迦南科技上市以后，按“一体两翼”战略围绕大健康产业对流体装备、粉体装备产业迅速布局，完成从单机设备到整体综合性解决方案的发展。目前可为客户提供固体制剂整线解决方案、原料药整线解决方案、制药用水系统、智能仓储物流系统、药品研发/中药检测综合服务、EPC工程总包等服务，广泛应用于制药、食品、保健品、精细化工、新能源、新材料等行业。迦南科技积极“响应中国制造2025、助力制药工业4.0”，成立了“迦南智造研究院”专门负责固体制剂智能化技术的开发，与同济大学合作在南京工厂建立“固体制剂智能样板线”，研发出符合GMP要求的AGV小车，可为制药企业提供固体制剂智能化解决方案。此外迦南公司还积极推动设备生产制造过程中的智能化，在温州基地推进“C—M数字化工厂”，是第一家在企业内部应用立体库及智能物流的制药装备企业。迦南科技以提升制药工艺水平、推动产业升级为已任，是目前唯一成立了“药学研究院”的制药装备企业。在南京市江苏生命科技创新园建立了小试实验室平台、检测实验室，可为制药企业提供创新药技术合作、仿制药一致性评价外包服务、固体制剂缓控释制剂技术合作、制剂工艺开发与支持、中药检测等服务。迦南科技产品远销美国、德国、加拿大、意大利、日本、韩国等国家和地区，深受国内外广大用户的认可。与辉瑞、拜耳、强生、葛兰素史克、赛诺菲、哈药集团、中国医药集团、石药集团、上海医药集团、云南白药、恒瑞医药、复星医药、天士力、华润三九、人福药业、以岭药业等国内外知名制药企业建立了长期合作关系。迦南科技持续“专注健康价值”，倡导“守正创新协同共赢卓越致远”的企业文化，以提升制药工艺水平、推动产业升级为已任，致力于为客户提供更全面、更专业的一站式服务，争做药机行业的百年民族品牌和国际一流的制药装备产业集团。 | ||||||||||||||||||||||||
| Main Business | 制药装备制造业务 | ||||||||||||||||||||||||
| Legal Representative | 方正 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 晁虎 | ||||||||||||||||||||||||
| Solicitors | 北京德恒律师事务所 | ||||||||||||||||||||||||
| Auditors | 中汇会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0577-67976666 | ||||||||||||||||||||||||
| Fax No | 0577-67976666 | ||||||||||||||||||||||||
| Website | www.china-jianan.com/ | ||||||||||||||||||||||||
| dsb@china-jianan.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 31/12/2014 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.050 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 2.041 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 2.204B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |